Mette Reilev

Medicin og biovidenskab

1. Denmark 100%
2. Drug Utilization 96%
3. Severe Acute Respiratory Syndrome 82%
4. Coronavirus 80%
5. Odds Ratio 67%
6. Prescriptions 58%
7. Chronic Obstructive Pulmonary Disease 58%
8. Cohort Studies 45%
9. Population 45%
10. Nursing Homes 43%
11. Angiotensin Receptor Antagonists 43%
12. Human Influenza 39%
13. Adrenal Cortex Hormones 38%
14. brodalumab 38%
15. Registries 38%
16. Pharmaceutical Preparations 37%
17. Mortality 36%
18. Prescription Drugs 35%
19. Microscopic Colitis 33%
20. Hospitalization 33%
21. Multimorbidity 32%
22. SARS Virus 31%
23. Anti-Inflammatory Agents 31%
24. Scandinavian and Nordic Countries 30%
25. Omalizumab 30%
26. Intensive Care Units 30%
27. Lactulose 29%
28. Chronic Urticaria 28%
29. Budesonide 27%
30. Angiotensin-Converting Enzyme Inhibitors 27%
31. Bronchodilator Agents 27%
32. Proton Pump Inhibitors 26%
33. Morbidity 26%
34. Osteoporotic Fractures 25%
35. Histamine Antagonists 24%
36. Information Storage and Retrieval 23%
37. Polymerase Chain Reaction 22%
38. Renin-Angiotensin System 22%
39. Case-Control Studies 21%
40. Therapeutics 20%
41. Non-Steroidal Anti-Inflammatory Agents 19%
42. Calcium Channel Blockers 19%
43. Child 18%
44. Pneumonia 18%
45. Health 18%
46. Databases 18%
47. Epidemiology 16%
48. Observational Studies 16%
49. Vaccines 15%
50. Amoxicillin 15%